Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | X-376 |
| Synonyms | |
| Therapy Description |
X-376 is a small molecule inhibitor of Alk, which may reduce growth of ALK-driven tumor cells (PMID: 21613408). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| X-376 | ALK Inhibitor 33 | X-376 is a small molecule inhibitor of Alk, which may reduce growth of ALK-driven tumor cells (PMID: 21613408). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| EML4 - ALK | lung cancer | sensitive | X-376 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, X-376 inhibited Alk signaling, resulted in growth inhibition in lung cancer cells harboring EML4-ALK fusion in culture and in cell line xenograft models (PMID: 21613408). | 21613408 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|